Placenta cell shots aim to heal diabetic foot ulcers
NCT ID NCT01859117
First seen Jun 04, 2026 · Last updated Jun 18, 2026 · Updated 3 times
Summary
This early study tested whether injections of cells from donated placentas are safe for people with blocked leg arteries and diabetic foot ulcers. Fifteen adults with diabetes received one of several doses. The main goal was to check for side effects and find the safest dose. This is a first step to see if this approach might help heal wounds and improve blood flow.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIABETIC FOOT ULCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Carl T. Hayden Veterans Affairs Medical Center
Phoenix, Arizona, 85012, United States
-
Complete Family Foot Care - McAllen Office
McAllen, Texas, 78501-2930, United States
-
Dr. Wiliam M. Scholl College of Podiatric Medicine
North Chicago, Illinois, 60064, United States
-
Endeavor Clinical Trials PA
San Antonio, Texas, 78229, United States
-
Southern Illinois University School of Medicine
Springfield, Illinois, 62702, United States
-
UCLA
Los Angeles, California, 90095, United States
-
University of North Carolina School of Medicine
Chapel Hill, North Carolina, 27599, United States
-
University of Oklahoma Health Sciences Center
Oklahoma City, Oklahoma, 73104, United States
-
University of Virginia
Charlottesville, Virginia, 22908-0709, United States
-
University of Wisconsin
Madison, Wisconsin, 53792, United States
-
VA Palo Alto health
Palo Alto, California, 94304, United States
-
Vascular Surgeon
Minneapolis, Minnesota, 55407, United States
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.